Peptide therapy
DEPeptidtherapie
Peptide therapy uses short amino-acid chains, often injected, intended to modulate growth hormone (e.g., sermorelin, ipamorelin), tissue repair, or metabolism. A few peptides are approved for narrow indications, but most longevity uses are off-label or sourced as research chemicals. Human evidence for anti-aging endpoints is sparse, quality control of compounded products is variable, and regulatory bodies (e.g., FDA) have restricted several popular peptides.
Sources
- Anisimov VN, Khavinson VKh. (2010). Peptide bioregulation of aging: results and prospects. *Biogerontology*doi:10.1007/s10522-009-9249-8
- Mavrych V, Shypilova V, Bolgova O. (2026). Therapeutic peptides in gerontology: mechanisms and applications for healthy aging. *Frontiers in Aging*doi:10.3389/fragi.2026.1790247
